Clarification of Contraceptive Drug Pharmacokinetics in Obesity
Danielle PillsburyJanuary 1, 2017
Study Reanalysis Using a Mechanism-based Pharmacokinetic/Pharmacodynamic Model of Pramlintide in Subjects with Type 1 Diabetes
This report describes a pharmacokinetic/pharmacodynamic model for pramlintide, an amylinomimetic, in type 1 diabetes mellitus…
Danielle PillsburyJanuary 1, 2015
Population Pharmacokinetic Analysis of Dutogliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor
Dutogliptin is a selective dipeptidyl peptidase-4 inhibitor shown to be efficacious and safe in patients…
Danielle PillsburyJuly 14, 2014
Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects with Type 2 Diabetes Mellitus
The G-protein-coupled receptor 40 agonist (GPR40) TAK-875 is being developed as an adjunct to diet…
Danielle PillsburyJanuary 9, 2013
Population Pharmacokinetic Model for a Novel Oral Hypoglycemic Formed In Vivo: Comparing the Use of Active Metabolite Data Alone Versus Using Data of Upstream and Downstream Metabolites
The purpose of this analysis was to develop a population pharmacokinetic model for CS-917, an…
Danielle PillsburyMarch 1, 2012
The Use of Biosimulation in the Design of a Novel Multilevel Weight Loss Maintenance Program for Overweight Children
Weight loss outcomes achieved through conventional behavior change interventions are prone to deterioration over time.…
Danielle PillsburyFebruary 18, 2010
CYP2D6 is Primarily Responsible for the Metabolism of Clomiphene
Clomiphene is a first line treatment for anovulation, a common cause of infertility. Response to…
Danielle PillsburyApril 30, 2008
